UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 743

Sortiert nach

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies

Cancers, 2023-03, Vol.15 (6), p.1692

2023

Link zum Volltext

Verfügbarkeit prüfen

Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location

Investigative ophthalmology & visual science, 2013-02, Vol.54 (2), p.1106-1117

2013

Link zum Volltext

Verfügbarkeit prüfen

The effects of SFAS-123R on corporate investment

Applied economics letters, 2020-06, Vol.27 (10), p.803-809

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of vaccine stockout with immunisation coverage in low-income and middle-income countries: a retrospective cohort study

BMJ open, 2023-07, Vol.13 (7), p.e072364-e072364

2023

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Fatigue and Combustion Exposure of a SiC/SiC Ceramic Matrix Composite

Journal of composite materials, 2010-12, Vol.44 (25), p.2991-3016

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of Visual Deficits in Aging DBA/2J Mice by Two Behavioral Assays

Current eye research, 2011-05, Vol.36 (5), p.481-491

2011

Link zum Volltext

Verfügbarkeit prüfen

Lying in Wait: Modeling the Control of Bacterial Infections via Antibiotic-Induced Proviruses

mSystems, 2019-10, Vol.4 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Fatigue Behavior of Hi-Nicalon Type-S™/BN/SiC Ceramic Matrix Composites in a Combustion Environment

International journal of applied ceramic technology, 2011-03, Vol.8 (2), p.261-272

2011

Link zum Volltext

Verfügbarkeit prüfen

Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections

Journal of antimicrobial chemotherapy, 2016-04, Vol.71 (4), p.1071-1075

2016

Link zum Volltext

Verfügbarkeit prüfen

Managerial ability and cost of equity capital

Advances in accounting, 2024-06, Vol.65, p.100681, Article 100681

2024

Link zum Volltext

Verfügbarkeit prüfen

Sub-50 nm Terahertz In0.8Ga0.2As Quantum-Well High-Electron-Mobility Transistors for 6G Applications

IEEE transactions on electron devices, 2023-04, Vol.70 (4), p.2081-2089

2023

Link zum Volltext
IEEE_Xplore

Sub-30-nm In0.8Ga0.2As Composite-Channel High-Electron-Mobility Transistors With Record High-Frequency Characteristics

IEEE transactions on electron devices, 2021-04, Vol.68 (4), p.2010-2016

2021

Link zum Volltext
IEEE_Xplore

Phase II study of SM-88 in Ewing's and other sarcomas

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e23505-e23505

2021

Link zum Volltext

Verfügbarkeit prüfen

Sub-50 nm Terahertz In 0.8 Ga 0.2 As Quantum-Well High-Electron-Mobility Transistors for 6G Applications

IEEE transactions on electron devices, 2023-04, Vol.70 (4), p.2081-2089

2023

Link zum Volltext

Verfügbarkeit prüfen

Sub-30-nm In 0.8 Ga 0.2 As Composite-Channel High-Electron-Mobility Transistors With Record High-Frequency Characteristics

IEEE transactions on electron devices, 2021-04, Vol.68 (4), p.2010-2016

2021

Link zum Volltext

Verfügbarkeit prüfen

Results of NC-6300 (nanoparticle epirubicin) in an expansion cohort of patients with angiosarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11543-11543

2021

Link zum Volltext

Verfügbarkeit prüfen

High-performance uniform stepper-based InP double-heterojunction bipolar transistor (DHBT) on a 3-inch InP substrate

Solid-state electronics, 2024-07, Vol.217, p.108933, Article 108933

2024

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of a phase I study of SNK01 (Autologous Nongenetically Modified Natural Killer Cells with Enhanced Cytotoxicity) and avelumab in advanced refractory sarcoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11517-11517

2022

Link zum Volltext

Verfügbarkeit prüfen

GALLANT: A phase 2 study using metronomic gemcitabine, doxorubicin, nivolumab, and docetaxel as second/third-line therapy for advanced sarcoma (NCT04535713)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11518-11518

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study using ipilimumab, nivolumab, and trabectedin for previously untreated metastatic soft tissue sarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11562-11562

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular and morphological data reveal hybrid origin of wild Prunus yedoensis (Rosaceae) from Jeju Island, Korea: Implications for the origin of the flowering cherry

American journal of botany, 2014-11, Vol.101 (11), p.1976-1986

2014

Link zum Volltext

Verfügbarkeit prüfen

Preliminary analysis of a phase I study of SNK01 (Autologous Non-genetically Modified Natural Killer Cells With Enhanced Cytotoxicity) monotherapy in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2644-2644

2022

Link zum Volltext

Verfügbarkeit prüfen

Five-year results of a phase 2 trial using ipilimumab (I), nivolumab (N), and trabectedin (T) for previously untreated advanced soft tissue sarcoma (NCT03138161)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11573-11573

2022

Link zum Volltext

Verfügbarkeit prüfen

The authors reply

Pediatric critical care medicine, 2016-05, Vol.17 (5), p.476-476

2016

Link zum Volltext

Verfügbarkeit prüfen

The authors reply

Pediatric critical care medicine, 2016-05, Vol.17 (5), p.476

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(605)
Mit Volltextzugriff
(649)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(15)
Plos One
(15)
Euromoney
(11)
Blood
(10)
Proceedings Of The National Academy Of Sciences - Pnas
(10)
Nature
(9)
Cancer Research
(8)
Clinical Cancer Research
(8)
The Lancet
(8)
Nature Medicine
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies

Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location

The effects of SFAS-123R on corporate investment

Association of vaccine stockout with immunisation coverage in low-income and middle-income countries: a retrospective cohort study

Simultaneous Fatigue and Combustion Exposure of a SiC/SiC Ceramic Matrix Composite

Detection of Visual Deficits in Aging DBA/2J Mice by Two Behavioral Assays

Lying in Wait: Modeling the Control of Bacterial Infections via Antibiotic-Induced Proviruses

Fatigue Behavior of Hi-Nicalon Type-S™/BN/SiC Ceramic Matrix Composites in a Combustion Environment

Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections

Managerial ability and cost of equity capital

Sub-50 nm Terahertz In0.8Ga0.2As Quantum-Well High-Electron-Mobility Transistors for 6G Applications

Sub-30-nm In0.8Ga0.2As Composite-Channel High-Electron-Mobility Transistors With Record High-Frequency Characteristics

Phase II study of SM-88 in Ewing's and other sarcomas

Sub-50 nm Terahertz In 0.8 Ga 0.2 As Quantum-Well High-Electron-Mobility Transistors for 6G Applications

Sub-30-nm In 0.8 Ga 0.2 As Composite-Channel High-Electron-Mobility Transistors With Record High-Frequency Characteristics

Results of NC-6300 (nanoparticle epirubicin) in an expansion cohort of patients with angiosarcoma

High-performance uniform stepper-based InP double-heterojunction bipolar transistor (DHBT) on a 3-inch InP substrate

Interim analysis of a phase I study of SNK01 (Autologous Nongenetically Modified Natural Killer Cells with Enhanced Cytotoxicity) and avelumab in advanced refractory sarcoma

GALLANT: A phase 2 study using metronomic gemcitabine, doxorubicin, nivolumab, and docetaxel as second/third-line therapy for advanced sarcoma (NCT04535713)

A phase 2 study using ipilimumab, nivolumab, and trabectedin for previously untreated metastatic soft tissue sarcoma

Molecular and morphological data reveal hybrid origin of wild Prunus yedoensis (Rosaceae) from Jeju Island, Korea: Implications for the origin of the flowering cherry

Preliminary analysis of a phase I study of SNK01 (Autologous Non-genetically Modified Natural Killer Cells With Enhanced Cytotoxicity) monotherapy in patients with advanced solid tumors

Five-year results of a phase 2 trial using ipilimumab (I), nivolumab (N), and trabectedin (T) for previously untreated advanced soft tissue sarcoma (NCT03138161)

The authors reply

The authors reply

Suchergebnisse filtern